glp 1 china Novo Nordisk's diet drug may land in soon An international trade platform called

(The panel voted against including Emideltide.) But the PCACs guidance is a recommendation, not a final rulingand for now, nothing is changing for consumers

The volumetric finding is a hypothesis worth testing in a powered trial with volume change as a prespecified endpoint, not a demonstration that the drug protects brain tissue

,

Endocrinologists viewed their ideal patient as an individual with established cardiovascular disease or high cardiovascular risk, including those with diabetic kidney disease, who are already being treated with more than one oral medication (including either SGLT2is or GLP1-RAs) and an HbA1c level exceeding the established target